Robert John Aversa,Paul Andrew Barsanti,Matthew Burger,Michael Patrick Dillon,Alan Dipesa,Cheng Hu,Yan Lou,Gisele Nishiguchi,Yue Pan,Valery Polyakov,Savithri Ramurthy,Alice Rico,Lina Setti,Aaron Smith
申请号：
US14774431
公开号：
US09694016B2
申请日:
2014.03.13
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides compounds of Formula (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
